HOHL BENJAMIN (CHIEF FINANCIAL OFFICER) received a stock award from ENLIVEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2026ACC: 0001882764-26-000001
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
+175K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
175K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
69.4%
2/12/2026
36K→61K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +25K | — | — | 69.4% | 36K | 61K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
150K shares
Shares
+150K
Strike price
27.16
Held after
150K
Exercisable
—
2/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock150K shares | 2/12/2026 | A · Award | +150K | 27.16 | — | 150K |